Skip to content

The comparative study of the effect of Intratympanic dexamethasone and dexamathasone in gelfom after myringotomy in sudeen sensory neural hearing loss in Kashani and Al-zahra hospital in 2012-2013

Comparison of "intratympanic dexamethasone" with "Round Window Gelfoam and Middle Ear Injection of Methylprednisolone" in sudden sensorineural hearing loss

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201211062106N5
Enrollment
60
Registered
2014-10-15
Start date
2011-12-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing. Disease of inner ear, unspecified

Interventions

Intervention 1: Round Window Gelfoam and Middle Ear Injection of Methylprednisolone. Intervention 2: intratympanic dexamethasone.
Treatment - Surgery
Round Window Gelfoam and Middle Ear Injection of Methylprednisolone

Sponsors

Isfahan University of Medical Scinces, Vice challenry
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria : patients with SSNHL who referred to the Al- Zahra and Ayatollah Kashani hospitals of Isfahan; no improvement in SSNHL with conventional treatments and systemic steroids; no pregnancy; no organ transplantation and patient satisfaction to participate in the study. Exclusion criteria: patients who failed to follow-up one month after treatment and the ones on whom it was not possible to apply the treatment

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hearing. Timepoint: Before intervention and one month after intervention. Method of measurement: Pure Tone Audiometry.

Secondary

MeasureTime frame
Complication. Timepoint: During study. Method of measurement: Questioning about complication.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Nadalinejhad

Isfahan University of Medical Scinces

nadali.abbas@yahoo.com+98 31 3668 2525

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026